About Malecare

Malecare is the world's leading men's cancer support and advocacy nonprofit organization.

Outcomes Analysis of Pooled Individual Data from Randomized Clinical Trials of Degarelix versus Luteinising Hormone-Releasing Hormone Agonists

Degarelex (Firmagon) (approved by the FDA in December of 2008) is a hormonal therapy drug used to treat advanced prostate cancer that has become metastatic and castrate resistant (mCRPC). Degarelix is a GnRH receptor that binds to the pituitary GnRH receptors, reducing the release of gonadotropins leading to a quick and profound onset that blocks [...]

Good News from Bayer – The Xofigo Problem May Be Resolved & Bayer Hopes that the First Batch Will Be Delivered in November

Today, Bayer supplied Malecare with an update about the status of the Xofigo shortage. Bayer has told us that they have identified the cause of the problem and have implemented a system to resolve the problem. They are hopeful that the first batch of drug will able to be released in the month of November, [...]

We Need to Report Serious Adverse Events or Serious Drug Side Effects to the FDA – How You Can Make a Report

The Food and Drug Administration (FDA) is charged with protecting the general health and well being of Americans with medicines and certain treatment equipment. Sometimes these medications or treatment equipment fail, don't work as indicated or cause serious, life threatening side effects. Reporting these events is important so the FDA can track and monitor these [...]

Visit www.eventually.be for an absolutely moving experience about loss and grieving.

Something we hope our prostate cancer won't cause to our loved ones. Eventually is a collection of first person video testimonials about significant loss and bereavement. In each account, participants reflect upon their own experience, recount events leading up to and around the death of their family member or loved one, talk about how they [...]

By |2021-02-17T10:29:09-05:00October 29th, 2014|Advanced Prostate Cancer, Uncategorized|0 Comments
Go to Top